Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 41% ± 20% | |
lung | 15 studies | 41% ± 18% | |
kidney | 8 studies | 42% ± 15% | |
intestine | 8 studies | 39% ± 18% | |
liver | 7 studies | 47% ± 24% | |
heart | 5 studies | 32% ± 10% | |
adipose | 4 studies | 44% ± 21% | |
pancreas | 3 studies | 30% ± 11% | |
peripheral blood | 3 studies | 42% ± 27% | |
uterus | 3 studies | 40% ± 18% | |
eye | 3 studies | 37% ± 22% | |
esophagus | 3 studies | 27% ± 11% | |
bone marrow | 3 studies | 38% ± 28% | |
placenta | 3 studies | 30% ± 11% | |
skin | 3 studies | 43% ± 28% | |
breast | 3 studies | 26% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 690.83 | 1424 / 1445 | 99% | 5.79 | 181 / 183 |
lung | 100% | 1165.00 | 577 / 578 | 89% | 3.48 | 1024 / 1155 |
stomach | 99% | 862.27 | 356 / 359 | 83% | 3.29 | 237 / 286 |
breast | 99% | 975.68 | 456 / 459 | 81% | 3.50 | 908 / 1118 |
pancreas | 95% | 430.70 | 313 / 328 | 83% | 2.86 | 147 / 178 |
kidney | 99% | 633.56 | 88 / 89 | 77% | 3.21 | 693 / 901 |
intestine | 99% | 925.51 | 957 / 966 | 70% | 2.16 | 367 / 527 |
prostate | 98% | 486.13 | 240 / 245 | 69% | 2.06 | 348 / 502 |
thymus | 100% | 942.12 | 652 / 653 | 62% | 1.57 | 373 / 605 |
bladder | 100% | 687.10 | 21 / 21 | 55% | 1.72 | 277 / 504 |
uterus | 100% | 823.86 | 170 / 170 | 55% | 1.23 | 252 / 459 |
skin | 99% | 956.44 | 1790 / 1809 | 52% | 1.05 | 245 / 472 |
ovary | 100% | 864.39 | 180 / 180 | 50% | 0.80 | 213 / 430 |
liver | 95% | 427.75 | 214 / 226 | 45% | 1.07 | 182 / 406 |
adrenal gland | 98% | 630.60 | 252 / 258 | 37% | 0.66 | 85 / 230 |
blood vessel | 100% | 2048.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1122.04 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 96% | 403.87 | 771 / 803 | 0% | 0 | 0 / 0 |
heart | 92% | 548.51 | 789 / 861 | 0% | 0 | 0 / 0 |
brain | 25% | 76.69 | 663 / 2642 | 49% | 0.95 | 344 / 705 |
spleen | 61% | 200.95 | 148 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 1.85 | 27 / 45 |
eye | 0% | 0 | 0 / 0 | 31% | 0.67 | 25 / 80 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.32 | 7 / 29 |
peripheral blood | 23% | 199.79 | 211 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008104 | Biological process | protein localization |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0019901 | Molecular function | protein kinase binding |
Gene name | NBEAL1 |
Protein name | Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein) NBEAL1 protein Neurobeachin like 1 |
Synonyms | ALS2CR17 ALS2CR16 |
Description | |
Accessions | ENST00000683338.1 A0A804HIR8 ENST00000483147.2 ENST00000434469.1 A0A804HKS6 ENST00000414576.6 A0A804HJX4 ENST00000682108.1 ENST00000683001.1 ENST00000682787.1 H7C3C8 A0A804HKB6 ENST00000683969.1 A0A804HHU0 ENST00000449802.5 [Q6ZS30-2] ENST00000683091.1 A0A804HKC1 A0A804HI87 A0A804HJM0 H7BZA0 ENST00000681967.1 ENST00000683650.1 Q6ZS30 A0A804HJ72 A2RUL1 |